Skip to content

KLRS KLRS EPS (Basic)

EPS (Basic) at other companies

Eli Lilly logo
Eli LillyLLY
$8.27+169%
Merck & Co. logo
Merck & Co.MRK
-$1.72-186%
Amgen logo
AmgenAMGN
$3.37+4.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$6.99-7.8%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
-$0.99-52.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$0.40-5.3%

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Reported directly by KLRS in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's EPS (basic)?
KLRS (KLRS) reported EPS (basic) of -$0.46 in Q1 2026.
How has KLRS's EPS (basic) changed year-over-year?
KLRS's EPS (basic) increased by 81.7% year-over-year, from -$2.52 to -$0.46.
What is the long-term trend for KLRS's EPS (basic)?
Over 3 years (2021 to 2025), KLRS's EPS (basic) has grown at a 15.4% compound annual growth rate (CAGR), from -$2.74 to -$4.21.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.